ISSCA Pakistan 2026 | February 7–8, 2026 | Lahore, Pakistan
Lahore, Pakistan — The International Society for Stem Cell Application (ISSCA) proudly announces the ISSCA Pakistan: International Regenerative Medicine Conference, taking place February 7–8, 2026, in Lahore. As regenerative medicine continues to grow worldwide, Pakistan is emerging as a country with strong potential, motivated clinicians, and local leaders actively promoting innovation—yet in need of globally standardized training and certification. ISSCA’s arrival aims to bridge that gap by offering physicians access to the same scientific structure, international protocols, and professional validation available in leading medical centers around the world.
The conference will bring together global experts, local innovators, and emerging clinical talent in a two-day event focused on the future of regenerative therapies, peptide medicine, longevity science, inflammation control, and musculoskeletal repair.
“Pakistan has taken meaningful steps toward advancing regenerative medicine, and we are inspired by the leaders driving that movement. ISSCA’s mission here is to serve as the global platform where these innovators can converge, collaborate, and build the strategic alliances that will shape the future of regenerative and peptide-based medicine in the country.”
— Benito Novas, Founder of ISSCA
A Scientific Program Designed for an Emerging Regenerative Medicine Landscape
Pakistan’s medical sector is experiencing a steady shift toward advanced therapies, driven by patient demand and the growing interest of young clinicians in evidence-based innovation. ISSCA Pakistan 2026 will introduce a forward-looking scientific program covering:
- Cellular therapies and modern clinical applications
- Bioactive peptide protocols for longevity, metabolic balance, and immune support
- Regenerative aesthetics and tissue optimization
- Pain modulation, inflammation control, and functional repair
- Integrative models combining regenerative, functional, and preventive medicine
ISSCA will also highlight how emerging markets like Pakistan can accelerate safe and sustainable adoption of regenerative therapies through structured training and international certification.
Why ISSCA’s Arrival Matters for Pakistan
Pakistan is entering a pivotal era in medical innovation. While interest in regenerative and peptide-based therapies is rising, the country still faces challenges such as uneven access to training, fragmented clinical practices, and limited international validation. Local leaders and organizations have taken important steps forward, but global standardization is essential for safe, sustainable growth.
ISSCA’s arrival matters because it:
- Integrates Pakistan into a global medical ecosystem with recognized standards
- Supports local leaders by providing structured, evidence-based training
- Enhances patient safety through protocol-driven education
- Positions Pakistan as an emerging regional hub for regenerative medicine
- Connects local clinicians with international faculty and strategic partners
- Accelerates the modernization of clinical practice
ISSCA Pakistan 2026 is not just an educational event—it is a platform for long-term collaboration and transformation.
Call to Action: Registration Now Open
👉 Register Now at: https://issca.com
Early registration benefits include:
- Special Early-Bird pricing
- Priority access to certification programs
- Admission to MedConnect Pakistan
- Access to pre-event webinars and educational materials
About ISSCA
“The International Society for Stem Cell Application (ISSCA) is a leading organization in the field of regenerative medicine. It is dedicated to advancing the science and practice of stem cell therapy and regenerative medicine through education, certification, research, and training. ISSCA provides certification training in cities worldwide, recognizing the importance of standards and certifications in regenerative medicine as a medical specialty.”
About Global Stem Cells Group
“Global Stem Cells Group is a leading provider of regenerative medicine solutions, dedicated to advancing healthcare through innovative therapies. With a global presence and a multidisciplinary team of experts, the organization strives to harness the potential of stem cells and regenerative medicine to improve patient outcomes across various medical fields. Through its extensive network of clinics, research facilities, and training centers, Global Stem Cells Group is committed to pushing the boundaries of regenerative medicine and making a positive impact on global healthcare.”
Safe Harbor Statement
Statements in this news release may be “forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business, partly based on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
